EGFR and cancer: In several types of cancer cells, the binding of hyaluronan to CD44 results in direct or indirect interaction of CD44 with receptors that regulate oncogenic pathways, such as ErbB2, EGFR, and TGF-beta receptor type I, and can also lead to interaction with non-receptor kinases of the Src family or Ras family GTPases [96].